These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19644018)

  • 1. Combined low doses of PPARgamma and RXR ligands trigger an intrinsic apoptotic pathway in human breast cancer cells.
    Bonofiglio D; Cione E; Qi H; Pingitore A; Perri M; Catalano S; Vizza D; Panno ML; Genchi G; Fuqua SA; Andò S
    Am J Pathol; 2009 Sep; 175(3):1270-80. PubMed ID: 19644018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bid as a potential target of apoptotic effects exerted by low doses of PPARγ and RXR ligands in breast cancer cells.
    Bonofiglio D; Cione E; Vizza D; Perri M; Pingitore A; Qi H; Catalano S; Rovito D; Genchi G; Andò S
    Cell Cycle; 2011 Jul; 10(14):2344-54. PubMed ID: 21654191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor-gamma activates p53 gene promoter binding to the nuclear factor-kappaB sequence in human MCF7 breast cancer cells.
    Bonofiglio D; Aquila S; Catalano S; Gabriele S; Belmonte M; Middea E; Qi H; Morelli C; Gentile M; Maggiolini M; Andò S
    Mol Endocrinol; 2006 Dec; 20(12):3083-92. PubMed ID: 16887883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced effects of PPARgamma ligands and RXR selective retinoids in combination to inhibit migration and invasiveness in cancer cells.
    Papi A; Rocchi P; Ferreri AM; Guerra F; Orlandi M
    Oncol Rep; 2009 Apr; 21(4):1083-9. PubMed ID: 19288012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands.
    Crowe DL; Chandraratna RA
    Breast Cancer Res; 2004; 6(5):R546-55. PubMed ID: 15318936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoid X receptor and peroxisome proliferator-activated receptor-gamma agonists cooperate to inhibit matrix metalloproteinase gene expression.
    Burrage PS; Schmucker AC; Ren Y; Sporn MB; Brinckerhoff CE
    Arthritis Res Ther; 2008; 10(6):R139. PubMed ID: 19046432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of PPAR and RXR ligands in semaphorin 6B gene expression of human MCF-7 breast cancer cells.
    Murad H; Collet P; Huin-Schohn C; Al-Makdissy N; Kerjan G; Chedotal A; Donner M; Devignes MD; Becuwe P; Schohn H; Domenjoud L; Dauça M
    Int J Oncol; 2006 Apr; 28(4):977-84. PubMed ID: 16525649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
    Guan YF; Zhang YH; Breyer RM; Davis L; Breyer MD
    Neoplasia; 1999 Oct; 1(4):330-9. PubMed ID: 10935488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinational effect of PPARγ agonist and RXR agonist on the growth of SGC7901 gastric carcinoma cells in vitro.
    Liu Y; Zhu ZA; Zhang SN; Mou J; Liu L; Cui T; Pei DS
    Tumour Biol; 2013 Aug; 34(4):2409-18. PubMed ID: 23605322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 9-cis-Retinoic acid (9cRA), a retinoid X receptor (RXR) ligand, exerts immunosuppressive effects on dendritic cells by RXR-dependent activation: inhibition of peroxisome proliferator-activated receptor gamma blocks some of the 9cRA activities, and precludes them to mature phenotype development.
    Zapata-Gonzalez F; Rueda F; Petriz J; Domingo P; Villarroya F; de Madariaga A; Domingo JC
    J Immunol; 2007 May; 178(10):6130-9. PubMed ID: 17475839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand Activity of Group 15 Compounds Possessing Triphenyl Substituent for the RXR and PPARγ Nuclear Receptors.
    Hiromori Y; Ido A; Aoki A; Kimura T; Nagase H; Nakanishi T
    Biol Pharm Bull; 2016; 39(10):1596-1603. PubMed ID: 27725436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of retinoic acid receptor beta expression by peroxisome proliferator-activated receptor gamma ligands in cancer cells.
    James SY; Lin F; Kolluri SK; Dawson MI; Zhang XK
    Cancer Res; 2003 Jul; 63(13):3531-8. PubMed ID: 12839938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of retinoids and thiazolidinediones on proliferation, insulin release, insulin mRNA, GLUT 2 transporter protein and mRNA of INS-1 cells.
    Blumentrath J; Neye H; Verspohl EJ
    Cell Biochem Funct; 2001 Sep; 19(3):159-69. PubMed ID: 11494305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of p21 gene expression by peroxisome proliferator-activated receptor gamma in human lung carcinoma cells.
    Han S; Sidell N; Fisher PB; Roman J
    Clin Cancer Res; 2004 Mar; 10(6):1911-9. PubMed ID: 15041706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiazolidinediones inhibit growth of gastrointestinal, biliary, and pancreatic adenocarcinoma cells through activation of the peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
    Tsujie M; Nakamori S; Okami J; Hayashi N; Hiraoka N; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
    Exp Cell Res; 2003 Sep; 289(1):143-51. PubMed ID: 12941612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma.
    Haydon RC; Zhou L; Feng T; Breyer B; Cheng H; Jiang W; Ishikawa A; Peabody T; Montag A; Simon MA; He TC
    Clin Cancer Res; 2002 May; 8(5):1288-94. PubMed ID: 12006550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition.
    Avis I; Martínez A; Tauler J; Zudaire E; Mayburd A; Abu-Ghazaleh R; Ondrey F; Mulshine JL
    Cancer Res; 2005 May; 65(10):4181-90. PubMed ID: 15899809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of ERalpha signalling pathway by PPARgamma agonists: evidences of PPARgamma-independent events in two hormone-dependent breast cancer cell lines.
    Lecomte J; Flament S; Salamone S; Boisbrun M; Mazerbourg S; Chapleur Y; Grillier-Vuissoz I
    Breast Cancer Res Treat; 2008 Dec; 112(3):437-51. PubMed ID: 18204896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status.
    Fitzgerald P; Teng M; Chandraratna RA; Heyman RA; Allegretto EA
    Cancer Res; 1997 Jul; 57(13):2642-50. PubMed ID: 9205071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of peroxisome proliferator-activated receptor gamma and retinoid X receptor agonists induces sodium/iodide symporter expression and inhibits cell growth of human thyroid cancer cells.
    Chen JY; Wang JJ; Lee HC; Chi CW; Lee CH; Hsu YC
    J Chin Med Assoc; 2020 Oct; 83(10):923-930. PubMed ID: 33009242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.